Planned Combination with Modine Performance Technologies
Announced planned combination creating a pro forma $2.6B company with a pathway to >$3.5B revenue; pro forma synergy-adjusted EBITDA of ~13%; identified near-term run-rate cost synergies of ~$25M and a commercial synergy funnel >$100M (valves >50% of funnel) unlocking new end markets (power generation, heavy-duty equipment, commercial vehicles, data centers).
Significant Adjacent-Market Commercial Funnel
Generated an adjacent-market commercial funnel totaling >$300M of lifetime revenue outside light vehicle within months; rapid wins across commercial vehicles, powersports, and home & office; secured a global furniture brand award and began manufacturing/deliveries in January, demonstrating shorter development cycles and quick time-to-revenue.
Medical Product Innovation (ThermoFix) and FDA Progress
Submitted FDA 510(k) for the ThermoFix patient warming/securement system; expect revenue from ThermoFix later in 2026 and foresee Medical segment annual revenue growth accelerating into the high-teens; expect additional significant medical product announcement in early 2027 leveraging existing automotive IP.
Strong Automotive New Business Awards
Achieved $2.2B of automotive new business awards in 2025 (including $485M in Q4), highlighted by wins on Ford F-Series, Mercedes-Benz, and expanded adoption of pulse-based solutions — validating core technology demand.
Record Annual Revenue and Segment Growth
Reported record revenue of $1.5B in 2025, up 2.9% YoY (1.8% ex-FX); Automotive Climate & Comfort Solutions revenue increased 5.8% ex-FX; Q4 Climate & Comfort outgrew light vehicle by 820 basis points excluding FX.
Improved Cash Generation and Strong Balance Sheet
Generated $117M of operating cash flow (increase of ~7% YoY), reduced capital expenditures to $56M from $73M (down ~23%), and ended the year with net leverage of 0.2 turns, strengthening financial flexibility.
2026–2027 Outlook and Growth Visibility
Provided 2026 guidance of $1.5B–$1.6B revenue (~3% growth at midpoint ex-FX) and adjusted EBITDA of $175M–$195M (midpoint ~12% margin, ~30 bps expansion YoY). Introduced a preliminary 2027 revenue outlook of ~$1.7B (≈10% above 2026 midpoint) supported by launch cadence and adjacent-market contributions.
Operational and Strategic Initiatives
Rolled out company operating system and business-process standardization to drive operational rigor; pursuing footprint optimization and product mix improvements (lumbar/massage comfort, valves, pneumatics), positioning for margin expansion as growth scales.